Ranbaxy loses approvals, exclusivity of 2 drugs in US
The DC Federal Court in the US has upheld the decision of the USFDA for rescinding tentative approvals given to it for generic digestive disorder drug Nexium and antiviral Valcyte.
Mar 03, 2015, 15:50 PM IST